| Literature DB >> 17290220 |
Lauren F Stevenson1, Alison Sparks, Nerea Allende-Vega, Dimitris P Xirodimas, David P Lane, Mark K Saville.
Abstract
Mdm2 is an E3 ubiquitin ligase that promotes its own ubiquitination and also ubiquitination of the p53 tumour suppressor. In a bacterial two-hybrid screen, using Mdm2 as bait, we identified an Mdm2-interacting peptide that bears sequence similarity to the deubiquitinating enzyme USP2a. We have established that full-length USP2a associates with Mdm2 in cells where it can deubiquitinate Mdm2 while demonstrating no deubiquitinating activity towards p53. Ectopic expression of USP2a causes accumulation of Mdm2 in a dose-dependent manner and consequently promotes Mdm2-mediated p53 degradation. This differs from the behaviour of HAUSP, which deubiquitinates p53 in addition to Mdm2 and thus protects p53 from Mdm2-mediated degradation. We further demonstrate that suppression of endogenous USP2a destabilises Mdm2 and causes accumulation of p53 protein and activation of p53. Our data identify the deubiquitinating enzyme USP2a as a novel regulator of the p53 pathway that acts through its ability to selectively target Mdm2.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17290220 PMCID: PMC1852834 DOI: 10.1038/sj.emboj.7601567
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598